3 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Withdrawn 3 |
Follow Muscle Hypertonia: new trials by email Literature Review of Muscle Hypertonia trials Research Report on Muscle Hypertonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity onabotulinumtoxinA - Muscle Spasticity, Stroke | Phase 3 | Withdrawn | Allergan | 2014-08-01 | 2014-08-13 | |
| Continuous Intrathecal Baclofen Infusion for Chronic Spasticity Prometra Programmable Implantable Pump System - Spasticity | Phase 3 | Withdrawn | Flowonix Medical | 2010-01-01 | 2015-03-06 | |
| Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis. Sativex, Placebo - Spasticity, Multiple Sclerosis | Phase 3 | Withdrawn | GW Research Ltd | 2016-08-11 |
Muscle Spasticity (3) · Multiple Sclerosis (2) · Stroke (2) · Brain Injuries (1) · Cerebral Palsy (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1)
Muscular Diseases (3) · Musculoskeletal Diseases (3) · Neurologic Manifestations (3) · Neuromuscular Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2)
Botulinum Toxins, Type A (1) · nabiximols (1)
Allergan (1) · Flowonix Medical (1) · GW Research Ltd (1)